Background image

Learn about the Cala kIQ System – the science behind it, how it is used, and how people with essential tremor (ET) can get access to this therapy. The presenter for this virtual education event is Alex Kent, VP of Research at Cala Health. Cala kIQ is a wrist-worn device similar to a wrist watch, […]

BURLINGAME, Calif.–(BUSINESS WIRE)–Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today reported data demonstrating the increasing prevalence of essential tremor (ET) from 2010 to 2018; a high rate of depression and anxiety in patients with ET; and the safety and efficacy of Cala Trio when used in a real-world setting […]

BURLINGAME, Calif.–(BUSINESS WIRE)– Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, will present positive topline data from the landmark PROspective study for SymPtomatic relief of Essential tremor with Cala Therapy (PROSPECT) in a late-breaking poster presentation at the International Congress of Parkinson’s Disease and Movement Disorders on September 25, 2019, in Nice, France. Cala Therapy, […]

Posted on July 17, 2019

Patient recruitment is usually the biggest challenge in conducting clinical trials. Thanks to the International Essential Tremor Foundation and their members, Cala Health recently enrolled the largest therapeutic essential tremor study in record time. By Kate Rosenbluth,Founder/CEO of Cala Health, Inc. About five years ago, my co-founders and I spun Cala Health out from Stanford […]

Posted on August 1, 2018

Manish Gupta has over 15 years of experience in developing and executing global clinical trials in cardiac and neurological devices (including those developed to manage essential tremor). He shares how clinical trials work and how the IETF partners with Cala Health to recruit participants.  By Manish Gupta Vice President of Clinical Affairs Cala Health, Inc. […]

Categories: ET News, Research Study